Pyridostigmine induced heart block requiring ICU admission. Issue 5 (3rd September 2018)

• Record Type: Journal Article
• Authors: Chaucer, Benjamin; Whelan, Dustin; Lamichhane, Dronacharya
• Is Part Of: Journal of community hospital internal medicine perspectives. Volume 8:Issue 5(2018)
• Page Start: 283
• Page End: 284
• Publication Date: 2018-09-03
• Subjects: Heart block -- pyridostigmine -- ICU -- EKG -- myasthenia gravis; Internal medicine -- Periodicals; Hospitals -- Periodicals; Hospitals, Community; Internal Medicine; Hospitals; Internal medicine; Periodicals; Periodicals; 610
• DOI: 10.1080/20009666.2018.1527668
• Languages: English
• ISSNs: 2000-9666

Abstract

ABSTRACT: Myasthenia gravis is an autoimmune disorder that effects an estimated 20 people per 100, 000 in the USA per year. Pyridostigmine is a common drug used in the symptomatic treatment of myasthenia gravis. While generally safe and effective, a rare set of patients treated with pyridostigmine encounter cardiac conduction disorders. Here, we report a rare presentation of an adverse drug reaction due to pyridostigmine, which is important for its implications in the acute care setting.